Anyone want to guess why would a company with $250m in sales at 50% margin and 60m cash would be trading under its cash backing
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025